HR Execs on the Move

Codexis

www.codexis.com

 
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover and develop novel, high performance enzymes and novel biotherapeutics. Codexis enzymes have applications in the sustainable manufacturing of pharmaceuticals, food, and industrial products; in the creation of the next generation of life science tools; and as gene therapy and biologic therapeutics. The Company`s unique performance enzymes drive improvements such as: reduced energy usage, waste generation and capital requirements; higher yields; higher fidelity diagnostics; and more efficacious therapeutics. Codexis enzymes enable the promise of synthetic biology to improve the health of people and the planet.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.codexis.com
  • 200 Penobscot Drive
    Redwood City, CA USA 94063
  • Phone: 650.421.8100

Executives

Name Title Contact Details
Lyndsey Clogston
 Director, HR and Talent Management Profile
Svetlana Sowers
 Director, OEM Sales Profile
Catherine Mesgar
 Senior Director, People Operations and Technology Profile

Similar Companies

Encorium Group

Encorium Group, Inc is a Berwyn, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Diosynth

Diosynth is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Carolus Therapeutics

Carolus Therapeutics is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

emcresearch

emcresearch is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SeLux Diagnostics

SeLux Diagnostics is developing a Next Generation Phenotyping (NGP) platform that promises to transform infectious disease patient treatment by dramatically increasing the speed and accuracy with which targeted, personalized antibiotic therapies can be prescribed. Earlier, better-informed treatment decisions will save lives, improve patient outcomes, decrease hospital lengths of stay and hospital acquired infections, and help combat the global antibiotic resistance epidemic.